Carvedilol for Anthracycline Cardiomyopathy Prevention

Journal of the American College of Cardiology

Volumn 49, Issue 21, 2007, Pages 2142-

  Florenzano, Fernando ^a   Salman, Pamela ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CARVEDILOL; DOXORUBICIN; EPIRUBICIN;

BREAST CANCER; CARDIOMYOPATHY; CARDIOVASCULAR RISK; COMPARATIVE STUDY; DOSE RESPONSE; DRUG DOSE REGIMEN; DRUG EXPOSURE; DRUG INDICATION; HUMAN; LETTER; LYMPHOMA; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

EID: 34248638445     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.03.016     Document Type: Letter

References (2)

1. Kalay N., Basar E., Ozdogru I., et al. Protective effects of carvedilol against anthracycline-induced cardiomyopathy. J Am Coll Cardiol 48 (2006) 2258-2262
2. Swain M.S., Whaley F.S., and Ewer M.S. Congestive heart failure in patients treated with doxorubicin. Cancer 97 (2003) 2869-2879